No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Orton S, Bihoreau MT, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC.
Ramagopalan SV, et al.
J Neuroimmunol. 2007 May;186(1-2):156-60. doi: 10.1016/j.jneuroim.2007.02.003. Epub 2007 Mar 21.
J Neuroimmunol. 2007.
PMID: 17376543